Treatment of Impetigo
For limited impetigo, start with topical mupirocin 2% ointment applied three times daily for 5-7 days; for extensive disease involving multiple sites or when topical therapy is impractical, use oral antibiotics for 7 days targeting both S. aureus and streptococci. 1, 2
First-Line Treatment for Limited Disease
- Topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment for localized impetigo 1, 2, 3
- Retapamulin 1% ointment applied twice daily for 5 days is an effective alternative for limited disease 1
- The FDA confirms mupirocin's efficacy with clinical cure rates of 71% versus 35% for placebo, and 93% efficacy in head-to-head comparison with oral erythromycin 3
When to Use Oral Antibiotics
Oral antibiotics are indicated when: 1, 2
- Impetigo is extensive or involves multiple sites
- Topical therapy is impractical
- Treatment with topical antibiotics has failed
- Systemic symptoms are present
- Outbreaks affect several people (to decrease transmission)
Oral Antibiotic Regimens
For Methicillin-Susceptible S. aureus (MSSA):
- Dicloxacillin 250 mg four times daily for adults 1, 2
- Cephalexin 250-500 mg four times daily for adults 1, 2
- Treatment duration: 7 days 2
For Methicillin-Resistant S. aureus (MRSA):
- Clindamycin 300-450 mg three times daily for adults 1, 2
- Trimethoprim-sulfamethoxazole (TMP-SMX) - note this provides inadequate streptococcal coverage 1, 2, 4
- Doxycycline (not for children under 8 years) 1, 2
Critical Pitfalls to Avoid
- Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 1
- TMP-SMX covers MRSA but is inadequate for streptococcal infection, so consider combination therapy or alternative agents when streptococcal infection cannot be excluded 4
- Topical disinfectants are inferior to antibiotics and should not be used 5, 6
When to Obtain Cultures
Obtain cultures of vesicle fluid, pus, or erosions if: 1
- Treatment failure occurs
- MRSA is suspected
- Recurrent infections are present
- Antimicrobial therapy should be active against both S. aureus and streptococci 1
Pediatric Considerations
- Oral antibiotic dosing must be adjusted by weight for children 1
- Tetracyclines (doxycycline, minocycline) should not be used in children under 8 years of age 1
- Mupirocin demonstrated 78% efficacy in pediatric patients aged 2 months to 15 years versus 36% for placebo 3
Treatment Monitoring and Follow-up
- Re-evaluate if no improvement occurs after 48-72 hours of therapy 1, 2
- Topical treatment duration: 5-7 days 1, 2
- Oral antibiotic duration: 7 days 2
- Lesions should be kept covered with clean, dry bandages and good personal hygiene maintained to prevent spread 1, 2
Risk Factors for MRSA
Empiric therapy for community-acquired MRSA should be considered in patients with: 5
- Residence in long-stay care facilities
- Hospitalization within the preceding 30 days
- Recent antibiotic therapy (especially beta-lactams, cephalosporins, carbapenems, or quinolones)
- Failure to respond to first-line therapy